Leith Wheeler Investment Counsel Ltd. Abb Vie Inc. Transaction History

Leith Wheeler Investment Counsel Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $165,637 - $206,125	1,250 Added 8.93%	15,252 $2.05 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $130,149 - $149,886	900 Added 6.87%	14,002 $2.23 Million
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $435,676 - $522,490	3,150 Added 31.65%	13,102 $2.12 Million
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $449,603 - $515,665	3,350 Added 50.74%	9,952 $1.34 Million
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $376,115 - $478,165	2,733 Added 70.64%	6,602 $1.3 Million
Q1 2022 Apr 20, 2022	BUY	$131.98 - $163.75 $510,630 - $633,548	3,869 New	3,869 $627,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Leith Wheeler Investment Counsel Ltd., based on Form 13F filings with the SEC.

Stay updated on Leith Wheeler Investment Counsel Ltd. with notifications on news.